61 related articles for article (PubMed ID: 38508587)
1. Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer.
Agusti N; Kanbergs A; Nitecki R
Gynecol Oncol; 2024 Jun; 185():121-127. PubMed ID: 38402734
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling of primary endometrioid endometrial cancer and matched lung metastases:
Gordhandas S; Da Cruz Paula A; Kertowidjojo EC; Pareja F; Dessources K; da Silva EM; Derakhshan F; Mueller JJ; Abu-Rustum NR; Herman Chui M; Weigelt B
Gynecol Oncol Rep; 2024 Jun; 53():101391. PubMed ID: 38633674
[TBL] [Abstract][Full Text] [Related]
3. Mismatch-repair deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: A systematic review and meta-analysis.
Mitric C; Salman L; Abrahamyan L; Kim SR; Pechlivanoglou P; Chan KKW; Gien LT; Ferguson SE
Gynecol Oncol; 2023 Mar; 170():133-142. PubMed ID: 36682091
[TBL] [Abstract][Full Text] [Related]
4. Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature.
Dogan A; Schultheis B; Rezniczek GA; Hilal Z; Cetin C; Häusler G; Tempfer CB
Anticancer Res; 2017 Mar; 37(3):969-978. PubMed ID: 28314254
[TBL] [Abstract][Full Text] [Related]
5. Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
Manning-Geist BL; Rios-Doria E; Liu YL; Ellenson LH; Zhou QC; Iasonos A; Leitao MM; Abu-Rustum NR; Weigelt B; Mueller JJ
Int J Gynecol Cancer; 2024 May; 34(5):697-704. PubMed ID: 38508587
[TBL] [Abstract][Full Text] [Related]
6. Clinical patterns and genomic profiling of recurrent 'ultra-low risk' endometrial cancer.
Stasenko M; Feit N; Lee SSK; Shepherd C; Soslow RA; Cadoo KA; Alektiar K; Da Silva EM; Martins Sebastião AP; Leitao MM; Gardner G; Selenica P; Abu-Rustum NR; Weigelt B; Mueller JJ
Int J Gynecol Cancer; 2020 Jun; 30(6):717-723. PubMed ID: 32376737
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T
Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers.
Moroney MR; Davies KD; Wilberger AC; Sheeder J; Post MD; Berning AA; Fisher C; Lefkowits C; Guntupalli SR; Behbakht K; Corr BR
Gynecol Oncol; 2019 Jun; 153(3):517-520. PubMed ID: 30910249
[TBL] [Abstract][Full Text] [Related]
9. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
J Gynecol Oncol; 2023 Sep; 34(5):e85. PubMed ID: 37593813
[TBL] [Abstract][Full Text] [Related]
10. Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma.
Rios-Doria E; Momeni-Boroujeni A; Friedman CF; Selenica P; Zhou Q; Wu M; Marra A; Leitao MM; Iasonos A; Alektiar KM; Sonoda Y; Makker V; Jewell E; Liu Y; Chi D; Zamarin D; Abu-Rustum NR; Aghajanian C; Mueller JJ; Ellenson LH; Weigelt B
Gynecol Oncol; 2023 Jul; 174():262-272. PubMed ID: 37245486
[TBL] [Abstract][Full Text] [Related]
11. Safety of ovarian preservation for premenopausal patients with FIGO stage I grade 2 and 3 endometrioid endometrial adenocarcinoma.
Nasioudis D; Mastroyannis SA; Ko EM; Haggerty AF; Cory L; Giuntoli RL; Kim SH; Latif NA
Int J Gynecol Cancer; 2022 Jul; ():. PubMed ID: 35882426
[TBL] [Abstract][Full Text] [Related]
12. Demographic shifts associated with implementation of evidence-based guidelines for ovarian conservation in patients with endometrioid endometrial cancer.
Manning-Geist BL; Rios-Doria E; Aviki EM; Zhou Q; Iasonos A; Abu-Rustum NR; Brown CL; Mueller JJ
Int J Gynecol Cancer; 2022 Jul; ():. PubMed ID: 35831030
[TBL] [Abstract][Full Text] [Related]
13. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Oaknin A; Bosse TJ; Creutzberg CL; Giornelli G; Harter P; Joly F; Lorusso D; Marth C; Makker V; Mirza MR; Ledermann JA; Colombo N;
Ann Oncol; 2022 Sep; 33(9):860-877. PubMed ID: 35690222
[No Abstract] [Full Text] [Related]
14. Genomic landscape of endometrial carcinomas of no specific molecular profile.
Momeni-Boroujeni A; Nguyen B; Vanderbilt CM; Ladanyi M; Abu-Rustum NR; Aghajanian C; Ellenson LH; Weigelt B; Soslow RA
Mod Pathol; 2022 Sep; 35(9):1269-1278. PubMed ID: 35365770
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
